Literature DB >> 16218912

Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections.

H Lins1, C-W Wallesch, M T Wunderlich.   

Abstract

OBJECTIVE: To elucidate the relation between release patterns and cerebrospinal fluid/serum concentrations of neurobiochemical markers of cerebral damage and their potential value as monitoring parameters in central nervous system infections.
METHODS: We investigated protein S-100B and neuron-specific enolase (NSE) in 102 sequential cerebrospinal fluid (CSF)-serum-pairs in patients with bacterial (n = 11) or viral (n = 13) meningitis/meningoencephalitis and neuroborreliosis (n = 8) in comparison with controls (n = 13).
RESULTS: Highest S-100B values in CSF and serum were found on admission and showed a significant decrease afterwards. Comparison between disease groups revealed significant differences between bacterial and viral meningitis and neuroborreliosis for S-100B and also when compared with controls. NSE was not significantly elevated.
CONCLUSIONS: S-100B is altered in CNS infection but does not provide additional benefit in the differential diagnosis when compared with standard CSF parameters. Nevertheless, S-100B values might be used as an additional monitoring parameter especially when sequential lumbar punctures are contraindicated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16218912     DOI: 10.1111/j.1600-0404.2005.00484.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  8 in total

1.  B7 homolog 3 aggravates brain injury in a murine model of Streptococcus pneumoniae-induced meningitis.

Authors:  Xuqin Chen; Yanping Wang; Zhedong Wang; Ruhong Yan; Jie Liu; Xiangying Meng; Yan Li; Jianghuai Wang; Jian Wang
Journal:  Exp Ther Med       Date:  2015-03-05       Impact factor: 2.447

2.  Effect of anti-seizure drugs on serum S100B in patients with focal seizure: a randomized controlled trial.

Authors:  Rituparna Maiti; Biswa Ranjan Mishra; Monalisa Jena; Archana Mishra; Santanu Nath; Anand Srinivasan
Journal:  J Neurol       Date:  2018-09-01       Impact factor: 4.849

3.  Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections.

Authors:  Anna Grahn; Lars Hagberg; Staffan Nilsson; Kaj Blennow; Henrik Zetterberg; Marie Studahl
Journal:  J Neurol       Date:  2013-03-08       Impact factor: 4.849

4.  Cerebrospinal Fluid Studies in Kenyan Children with Severe Falciparum Malaria.

Authors:  N Mturi; G Keir; C A Maclennan; A Ross; A C Willis; B C Elford; J A Berkley; C R J C Newton
Journal:  Open Trop Med J       Date:  2008

5.  Evidence for a wide extra-astrocytic distribution of S100B in human brain.

Authors:  Johann Steiner; Hans-Gert Bernstein; Hendrik Bielau; Annika Berndt; Ralf Brisch; Christian Mawrin; Gerburg Keilhoff; Bernhard Bogerts
Journal:  BMC Neurosci       Date:  2007-01-02       Impact factor: 3.288

6.  Neuron-Specific Enolase Is Correlated to Compromised Cerebral Metabolism in Patients Suffering from Acute Bacterial Meningitis; An Observational Cohort Study.

Authors:  Jiri Bartek; Eric Peter Thelin; Per Hamid Ghatan; Martin Glimaker; Bo-Michael Bellander
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

7.  Case Report: Extreme Levels of Serum S-100B in a Patient with Chronic Subdural Hematoma.

Authors:  Malin Elisabet Persson; Eric Peter Thelin; Bo-Michael Bellander
Journal:  Front Neurol       Date:  2012-12-05       Impact factor: 4.003

Review 8.  Reliability of S100B in predicting severity of central nervous system injury.

Authors:  Stephen M Bloomfield; James McKinney; Les Smith; Jonathan Brisman
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.532

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.